82 related articles for article (PubMed ID: 6653660)
1. The monoamine oxidase inhibiting properties of CGP 11305 A.
Waldmeier PC; Felner AE; Tipton KF
Eur J Pharmacol; 1983 Oct; 94(1-2):73-83. PubMed ID: 6653660
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A.
Hurst JH; Kulakowski EC
Life Sci; 1986 Oct; 39(16):1471-7. PubMed ID: 2430159
[TBL] [Abstract][Full Text] [Related]
3. CGP 4718 A, a new potential antidepressant with a dual mode of action.
Waldmeier PC; Tipton KF; Bernasconi R; Felner AE; Baumann PA; Maitre L
Eur J Pharmacol; 1984 Dec; 107(1):79-89. PubMed ID: 6526072
[TBL] [Abstract][Full Text] [Related]
4. Reversibility of the interaction of CGP 11305 A with MAO A in vivo.
Waldmeier PC; Feldtrauer JJ; Stoecklin K; Paul E
Eur J Pharmacol; 1983 Oct; 94(1-2):101-8. PubMed ID: 6197309
[TBL] [Abstract][Full Text] [Related]
5. Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain.
Waldmeier PC; Baumann PA
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):20-6. PubMed ID: 6195533
[TBL] [Abstract][Full Text] [Related]
6. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
7. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase.
Fuller RW; Hemrick-Luecke SK; Molloy BB
Biochem Pharmacol; 1983 Apr; 32(7):1243-9. PubMed ID: 6847714
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase inhibition by novel antidepressant tetrindole.
Medvedev AE; Kirkel AA; Kamyshanskaya NS; Moskvitina TA; Axenova LN; Gorkin VZ; Andreeva NI; Golovina SM; Mashkovsky MD
Biochem Pharmacol; 1994 Jan; 47(2):303-8. PubMed ID: 8304974
[TBL] [Abstract][Full Text] [Related]
9. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
Severina IS; Klimova GI; Nersisian AA
Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of the effects of RS-8359 and safrazine on monoamine oxidase in-vitro and in-vivo in mouse brain.
Yokoyama T; Karube T; Iwata N
J Pharm Pharmacol; 1989 Jan; 41(1):32-6. PubMed ID: 2565961
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A.
Waldmeier PC; Antonin KH; Feldtrauer JJ; Grunenwald C; Paul E; Lauber J; Bieck P
Eur J Clin Pharmacol; 1983; 25(3):361-8. PubMed ID: 6628524
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
Deverina IS
Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
14. [Selective inhibition by pyrazidol of monoamine oxidase type A in different human and animal tissues].
Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
Vopr Med Khim; 1983; 29(5):118-23. PubMed ID: 6649522
[TBL] [Abstract][Full Text] [Related]
15. The hypothermic effect of 4-(5,6-dimethyl-2-benzofuranyl) piperidine HCl (CGP 6085 A) in Wistar Kyoto rats.
Kulakowski EC; Hurst JH; Miller T; Linnoila M; Lovenberg W
Life Sci; 1984 Sep; 35(12):1329-35. PubMed ID: 6237238
[TBL] [Abstract][Full Text] [Related]
16. Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake.
Ortmann R; Radeke E; Buech O; Sigg K; Rogg H; Glatt A; Truog A; Jaekel J; Everitt BJ; Delini-Stula A
Arzneimittelforschung; 1986 Dec; 36(12):1727-32. PubMed ID: 3566833
[TBL] [Abstract][Full Text] [Related]
17. Preferential inhibition of the B-form of monoamine oxidase in the liver of rats given 3'-methyl-4-dimethylaminoazobenzene in the diet.
Egashira T; Yamamoto T; Yamanaka Y; Kuroiwa Y
Biochem Pharmacol; 1982 Apr; 31(7):1301-7. PubMed ID: 6807318
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory actions of hydralazine upon monoamine oxidizing enzymes in the rat.
Lyles GA; Garcia-Rodriguez J; Callingham BA
Biochem Pharmacol; 1983 Sep; 32(17):2515-21. PubMed ID: 6615547
[TBL] [Abstract][Full Text] [Related]
19. [Selective inhibition of type A monoamine oxidase by pyrazidol].
Mashkovskiĭ MD; Gorkin VZ; Verevkina IV; Asnina VV; Tupikina SM
Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552
[TBL] [Abstract][Full Text] [Related]
20. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
